Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novel ADC Could Expand Treatment Options in Ovarian Cancer

(MedPage Today) -- Updated results from the FONTANA trial presented at the annual European Society for Medical Oncology congress showed promising activity with the investigational antibody-drug conjugate (ADC) torvutatug samrotecan (torvu-sam...

Novel ADC Could Expand Treatment Options in Ovarian Cancer

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 18 November →